An Analysis Based on Molecular Docking and Molecular Dynamics Simulation Study of Bromelain as Anti-SARS-CoV-2 Variants

被引:26
|
作者
Tallei, Trina Ekawati [1 ,2 ]
Fatimawali [2 ,3 ]
Yelnetty, Afriza [4 ]
Idroes, Rinaldi [5 ]
Kusumawaty, Diah [6 ]
Bin Emran, Talha [7 ]
Yesiloglu, Talha Zahid [8 ]
Sippl, Wolfgang [8 ]
Mahmud, Shafi [9 ]
Alqahtani, Taha [10 ]
Alqahtani, Ali M. [10 ]
Asiri, Saeed [11 ]
Rahmatullah, Mohammed [12 ]
Jahan, Rownak [12 ]
Khan, Md Arif [12 ]
Celik, Ismail [13 ]
机构
[1] Sam Ratulangi Univ, Fac Math & Nat Sci, Dept Biol, Manado, Indonesia
[2] Sam Ratulangi Univ, Univ Ctr Excellence Biotechnol & Conservat Wallac, Inst Res & Community Serv, Manado, Indonesia
[3] Sam Ratulangi Univ, Fac Math & Nat Sci, Pharm Study Program, Manado, Indonesia
[4] Sam Ratulangi Univ, Fac Anim Husb, Dept Anim Prod, Manado, Indonesia
[5] Univ Syiah Kuala, Fac Math & Nat Sci, Dept Pharm, Banda Aceh, Indonesia
[6] Univ Pendidikan Indonesia, Fac Math & Nat Sci Educ, Dept Biol, Bandung, Indonesia
[7] BGC Trust Univ Bangladesh, Dept Pharm, Chittagong, Bangladesh
[8] Martin Luther Univ Halle Wittenberg, Inst Pharm, Halle, Germany
[9] Univ Rajshahi, Dept Genet Engn & Biotechnol, Microbiol Lab, Rajshahi, Bangladesh
[10] King Khalid Univ, Coll Pharm, Dept Pharmacol, Abha, Saudi Arabia
[11] Najran Univ, Coll Appl Med Sci, Dept Clin Lab Sci, Najran, Saudi Arabia
[12] Univ Dev Alternat, Dept Biotechnol & Genet Engn, Dhaka, Bangladesh
[13] Erciyes Univ, Fac Pharm, Dept Pharmaceut Chem, Kayseri, Turkey
关键词
bromelain; receptor-binding domain; SARS-CoV-2; mutation; variants; WEB SERVER; BINDING-AFFINITY; PROTEIN; CLUSPRO; VIRUS;
D O I
10.3389/fphar.2021.717757
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The rapid spread of a novel coronavirus known as SARS-CoV-2 has compelled the entire world to seek ways to weaken this virus, prevent its spread and also eliminate it. However, no drug has been approved to treat COVID-19. Furthermore, the receptor-binding domain (RBD) on this viral spike protein, as well as several other important parts of this virus, have recently undergone mutations, resulting in new virus variants. While no treatment is currently available, a naturally derived molecule with known antiviral properties could be used as a potential treatment. Bromelain is an enzyme found in the fruit and stem of pineapples. This substance has been shown to have a broad antiviral activity. In this article, we analyse the ability of bromelain to counteract various variants of the SARS-CoV-2 by targeting bromelain binding on the side of this viral interaction with human angiotensin-converting enzyme 2 (hACE2) using molecular docking and molecular dynamics simulation approaches. We have succeeded in making three-dimensional configurations of various RBD variants using protein modelling. Bromelain exhibited good binding affinity toward various variants of RBDs and binds right at the binding site between RBDs and hACE2. This result is also presented in the modelling between Bromelain, RBD, and hACE2. The molecular dynamics (MD) simulations study revealed significant stability of the bromelain and RBD proteins separately up to 100 ns with an RMSD value of 2 angstrom. Furthermore, despite increases in RMSD and changes in Rog values of complexes, which are likely due to some destabilized interactions between bromelain and RBD proteins, two proteins in each complex remained bonded, and the site where the two proteins bind remained unchanged. This finding indicated that bromelain could have an inhibitory effect on different SARS-CoV-2 variants, paving the way for a new SARS-CoV-2 inhibitor drug. However, more in vitro and in vivo research on this potential mechanism of action is required.
引用
收藏
页数:18
相关论文
共 50 条
  • [41] Molecular networking unveils anti-SARS-CoV-2 constituents from traditionally used remedies
    Wasilewicz, Andreas
    Bojkova, Denisa
    Beniddir, Mehdi A.
    Cinatl Jr, Jindrich
    Rabenau, Holger F.
    Grienke, Ulrike
    Rollinger, Judith M.
    Kirchweger, Benjamin
    JOURNAL OF ETHNOPHARMACOLOGY, 2024, 319
  • [42] From Anti-SARS-CoV-2 Immune Response to the Cytokine Storm via Molecular Mimicry
    Kanduc, Darja
    ANTIBODIES, 2021, 10 (04)
  • [43] How Deep Learning in Antiviral Molecular Profiling Identified Anti-SARS-CoV-2 Inhibitors
    Ali, Mohammed
    Park, In Ho
    Kim, Junebeom
    Kim, Gwanghee
    Oh, Jooyeon
    You, Jin Sun
    Kim, Jieun
    Shin, Jeon-Soo
    Yoon, Sang Sun
    BIOMEDICINES, 2023, 11 (12)
  • [44] In Silico Identification and Analysis of Potentially Bioactive Antiviral Phytochemicals against SARS-CoV-2: A Molecular Docking and Dynamics Simulation Approach
    Halder, Sajal Kumar
    Sultana, Ive
    Shuvo, Md Nazmussakib
    Shil, Aparna
    Himel, Mahbubul Kabir
    Hasan, Md. Ashraful
    Shawan, Mohammad Mahfuz Ali Khan
    BIOMED RESEARCH INTERNATIONAL, 2023, 2023
  • [45] Repurposing of phytomedicine-derived bioactive compounds with promising anti-SARS-CoV-2 potential: Molecular docking, MD simulation and drug-likeness/ADMET studies
    Rudrapal, Mithun
    Gogoi, Neelutpal
    Chetia, Dipak
    Khan, Johra
    Banwas, Saeed
    Alshehri, Bader
    Alaidarous, Mohammed A.
    Laddha, Umesh D.
    Khairnar, Shubham J.
    Walode, Sanjay G.
    SAUDI JOURNAL OF BIOLOGICAL SCIENCES, 2022, 29 (04) : 2432 - 2446
  • [46] A Computational Study on Selected Alkaloids as SARS-CoV-2 Inhibitors: PASS Prediction, Molecular Docking, ADMET Analysis, DFT, and Molecular Dynamics Simulations
    Mortuza, Md. Golam
    Roni, Md Abul Hasan
    Kumer, Ajoy
    Biswas, Suvro
    Abu Saleh, Md.
    Islam, Shirmin
    Sadaf, Samia
    Akther, Fahmida
    BIOCHEMISTRY RESEARCH INTERNATIONAL, 2023, 2023
  • [47] Molecular Determinants of SARS-CoV-2 Variants
    Banerjee, Arinjay
    Mossman, Karen
    Grandvaux, Nathalie
    TRENDS IN MICROBIOLOGY, 2021, 29 (10) : 871 - 873
  • [48] Identification of natural compounds as SARS-CoV-2 inhibitors via molecular docking and molecular dynamic simulation
    Han, Tiantian
    Luo, Ziqing
    Ji, Lichun
    Wu, Peng
    Li, Geng
    Liu, Xiaohong
    Lai, Yanni
    FRONTIERS IN MICROBIOLOGY, 2023, 13
  • [49] Epitope Analysis of Anti-SARS-CoV-2 Neutralizing Antibodies
    Jun-biao Xue
    Sheng-ce Tao
    Current Medical Science, 2021, 41 : 1065 - 1074
  • [50] Targeting the main SARS-Cov-2 pathways with peptide inhibitors by molecular docking and molecular simulation approaches
    Jin, Jianchang
    Wang, Nan
    Wang, Shilei
    Alsaikhan, Fahad
    Ahmad, Irfan
    JOURNAL OF MOLECULAR LIQUIDS, 2024, 398